The Epidemiology And Control Of Sexually Transmitted Infections Within Australia.
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Sexually transmitted infections (STIs) such as chlamydia are increasing. Without effective vaccines, STIs can only be controlled by behavioral or screening interventions. This program of research will help us understand how STIs such as chlamydia, Mycoplasma genitalium, HPV and bacterial vaginosis spread among Australians and will help us to determine how best to control them.
Gonorrhoea: Detection, Antimicrobial Resistance And Treatment.
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
Rates of gonorrhoea are extremely high in Indigenous populations of Australia, and the gonorrhoea bug has now developed resistance to almost all antibiotics that have been used to treat it. In this study, we will investigate a new means of diagnosing the infection, as well as better ways to detect gonorrhoea drug resistance. By doing so, we will ensure that gonorrhoea infections are better managed, particularly in our Indigenous populations.
Prevention Of Sexually Transmissible Infections In Australia
Funder
National Health and Medical Research Council
Funding Amount
$415,218.00
Summary
Australians experience a substantial burden of health and social consequences related to sexually transmissible infections (STIs). The Career Development Fellowship will enable me to conduct research to improve sexual health of people at risk of STIs, through evaluating new strategies that increase the accessibility of STI testing; information technology to improve the efficiency of health services; and a better understanding of the impact of social media on young people’s sexual health.
The Role Of The Complement System In Neurodegeneration And The Therapeutic Potential Of Complement Inhibition
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
This project aims to identify the role of immune and inflammatory components in the pathology of neurodegenerative disease. Additionally, this research will determine whether a new class of novel anti-inflammatory drugs can alter the neurodegenerative process. This will allow for an increased understanding of the biology of neurodegenerative disease, and also may lead to the development of new treatments for conditions such as Parkinson’s disease, Huntington’s disease and motor neuron disease.
Investigatin The Causes Of Failed Efferocytosis In COPD-emphysema With A View To Identifying Novel Theraputic Targets
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
COPD is a leading cause of death. Smoking is the major cause of COPD and many sufferers are left with permanent damage and need ongoing treatment even after smoking cessation. Current treatments for COPD generally have limited efficacy. The project will identify the reason for the large number of dying cells and defective clearance of these cells that we have identified in the airways in COPD and study novel treatments that we hope will improve the health and well being of those with COPD.
Gene Discovery And Pathobiology In Muscle Diseases
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
I aim to find the genetic causes of muscle diseases that are lethal or severely debilitating. These diseases result in a significant burden to the affected individuals and their families and also on Australia’s Health care system. A genetic diagnosis provides families with answers, allows family planning, such that couples do not have another affected child, enables appropriate clinical management and gives researchers evidence as to how to develop treatments.